Emicizumab, designated bROmI is embodying a important step forward in the field of these genetic disorder. This novel therapy functions as a prothrombin activator , substituting for factor VIII, a https://xanderommv261526.pointblog.net/emicizumab-a-new-hope-for-bleeding-disorders-treatment-92132339